Dual targeting nanoparticles for epilepsy therapy

For epilepsy therapy, one-third of the patients worldwide are resistant to antiepileptic drugs mainly due to the existence of the blood–brain barrier (BBB) that prevents the drugs from reaching the epileptic lesions. Here, we design a double targeting nanoparticle carrying lamotrigine (LTG) to cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Qinghong, Wang, Lulu, Xiao, Feng, Wang, Le, Liu, Xiaoyan, Zhu, Lina, Lu, Yi, Zheng, Wenfu, Jiang, Xingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645397/
https://www.ncbi.nlm.nih.gov/pubmed/36519053
http://dx.doi.org/10.1039/d2sc03298h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645397/
https://www.ncbi.nlm.nih.gov/pubmed/36519053
http://dx.doi.org/10.1039/d2sc03298h

Ejemplares similares